Title |
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
|
---|---|
Published in |
Frontiers in Neuroscience, March 2015
|
DOI | 10.3389/fnins.2015.00092 |
Pubmed ID | |
Authors |
Kristy M. Heppner, Diego Perez-Tilve |
Abstract |
Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions. In addition to its incretin action, GLP-1 acts on the GLP-1 receptor (GLP-1R) in the brain to suppress feeding. These combined actions of GLP-1R signaling cause improvements in glycemic control as well as weight loss in type II diabetes (T2DM) patients treated with GLP-1R agonists. This is a superior advantage of GLP-1R pharmaceuticals as many other drugs used to treat T2DM are weight neutral or actual cause weight gain. This review summarizes GLP-1R action on energy and glucose metabolism, the effectiveness of current GLP-1R agonists on weight loss in T2DM patients, as well as GLP-1R combination therapies. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 1% |
Italy | 1 | 1% |
South Africa | 1 | 1% |
Spain | 1 | 1% |
United States | 1 | 1% |
Unknown | 93 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 22% |
Student > Bachelor | 16 | 16% |
Researcher | 15 | 15% |
Student > Postgraduate | 6 | 6% |
Professor > Associate Professor | 6 | 6% |
Other | 18 | 18% |
Unknown | 15 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 18 | 18% |
Medicine and Dentistry | 16 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 12% |
Agricultural and Biological Sciences | 12 | 12% |
Neuroscience | 8 | 8% |
Other | 13 | 13% |
Unknown | 19 | 19% |